Cidara

$2.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.62%) Today
-$0.06 (-2.47%) As of 11:30 PM UTC after-hours

Why Robinhood?

You can buy or sell Cidara and other stocks, options, and ETFs commission-free!

About CDTX

Cidara Therapeutics, Inc. Common Stock, also called Cidara, is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA. The listed name for CDTX is Cidara Therapeutics, Inc. Common Stock.

CEO
Jeffrey L. Stein
Employees
68
Headquarters
San Diego, California
Founded
2012
Market Cap
112.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.54M
High Today
$2.54
Low Today
$2.38
Open Price
$2.50
Volume
741.86K
52 Week High
$4.45
52 Week Low
$1.30

CDTX Earnings

-$0.56
-$0.35
-$0.13
$0.08
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

SFTW+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure